Mental Health World Conference 2026

Key topics to be considered in the session include recent breakthroughs in multimodal treatments, classifications, and diagnostics of mood disorders across various stages of life. Foreign experts will share their latest research findings concerning biological markers, new pharmaceutical drugs, psychotherapeutic programs, and aspects of diagnosing and managing this disease. Specifically, the session will pay special attention to such problems as treatment of patients with complex clinical conditions, treatment of drug-refractory cases of depression, the application of digital technologies, and cultural sensitivity of treatments.

 

One of many topics to be considered in this educational session is the enhancement of current knowledge of the most effective multimodal treatment strategies for mood disorders. The latest developments in pharmacological agents, psychotherapy, and technology-assisted therapies will be extensively explored at the MHWC 2026 conference. For instance, participants will discuss cutting-edge advancements in pharmacotherapy, including the development of antidepressants, mood stabilizers, and treatments for TRD. Meanwhile, considerable attention will be paid to the importance of evidence-based psychotherapy and integrative techniques, like CBT and interpersonal therapy.